Skip to content

BIO ESSENCE CORP.: 10-Q filed 2024-11-14

What BIO ESSENCE CORP. reported in its quarterly report filed 2024-11-14 (fiscal Q3 2024): 45 published measures, 116 facts as tagged in accession 0001213900-24-098180.

This filing

Form
10-Q (quarterly report)
Filed
2024-11-14
Fiscal period
fiscal Q3 2024
Accession
0001213900-24-098180 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIO ESSENCE CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-09-30715,973USD
At 2023-12-312,758,580USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-09-303,657,500USD
At 2023-12-314,418,874USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-09-30-2,941,527USD
At 2024-06-30-1,742,034USD
At 2024-03-31-1,526,356USD
At 2023-12-31-1,660,294USD
At 2023-09-30-1,466,608USD
At 2023-06-30-1,151,766USD
At 2023-03-31-3,417,251USD
At 2022-12-31-3,238,415USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-09-3029,818USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-1,199,493USD92
2024-01-01 to 2024-09-30-1,281,233USD274
2024-04-01 to 2024-06-30-215,678USD91
2024-01-01 to 2024-03-31133,938USD91
2023-07-01 to 2023-09-30-314,842USD92
2023-01-01 to 2023-09-30-778,192USD273
2023-04-01 to 2023-06-30-284,515USD91
2023-01-01 to 2023-03-31-178,836USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-09-30200,799USD274
2023-01-01 to 2023-09-30-821,579USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2023-01-01 to 2023-09-303,614USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2024-07-01 to 2024-09-30134,690USD92
2024-01-01 to 2024-09-30176,385USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-170,981USD274
2023-01-01 to 2023-09-30819,020USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-3,614USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-09-30-10,421,707USD
At 2023-12-31-9,140,474USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-07-01 to 2024-09-3038,009,000shares92
2024-01-01 to 2024-09-3038,009,000shares274
2023-07-01 to 2023-09-3038,009,000shares92
2023-01-01 to 2023-09-3035,261,747shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-0.03USD/shares92
2024-01-01 to 2024-09-30-0.03USD/shares274
2023-07-01 to 2023-09-30-0.01USD/shares92
2023-01-01 to 2023-09-30-0.02USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-0.03USD/shares92
2024-01-01 to 2024-09-30-0.03USD/shares274
2023-07-01 to 2023-09-30-0.01USD/shares92
2023-01-01 to 2023-09-30-0.02USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-01-01 to 2024-09-30800USD274
2023-01-01 to 2023-09-301,600USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-12-313,688USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-146,448USD92
2024-01-01 to 2024-09-30-463,290USD274
2023-07-01 to 2023-09-30-82,644USD92
2023-01-01 to 2023-09-30-150,114USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-09-30715,582USD
At 2023-12-31300,000USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-09-303,066,968USD
At 2023-12-312,450,456USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-09-3032,110USD
At 2023-12-3112,453USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2024-09-30391USD
At 2023-12-31567USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2024-09-3065,470USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-07-01 to 2024-09-30227,440USD92
2024-01-01 to 2024-09-30573,469USD274
2023-07-01 to 2023-09-3082,644USD92
2023-01-01 to 2023-09-30150,114USD273

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2024-07-01 to 2024-09-3080,992USD92
2024-01-01 to 2024-09-30110,179USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2024-07-01 to 2024-09-3053,698USD92
2024-01-01 to 2024-09-3066,206USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-09-3038,009,000shares
At 2023-12-3138,009,000shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-09-3029,818USD
At 2023-09-3089USD
At 2022-12-316,262USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-09-307,476,379USD
At 2023-12-317,476,379USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2023-12-311,427,918USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2024-09-3056,794USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2024-09-3056,505USD
At 2023-12-3160,119USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2024-09-3056,505USD
At 2023-12-3156,431USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2024-09-30391USD
At 2023-12-31567USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2024-09-30391USD
At 2023-12-311,484,718USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2024-09-30590,532USD
At 2023-12-31991,529USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-1,199,493USD92
2024-01-01 to 2024-09-30-1,537,358USD274
2023-07-01 to 2023-09-30-105,050USD92
2023-01-01 to 2023-09-30-219,956USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-07-01 to 2024-09-30227,440USD92
2024-01-01 to 2024-09-30573,469USD274
2023-07-01 to 2023-09-3082,644USD92
2023-01-01 to 2023-09-30150,114USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2024-01-01 to 2024-09-30677USD274
2023-07-01 to 2023-09-302,370USD92
2023-01-01 to 2023-09-307,059USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2024-07-01 to 2024-09-3059USD92
2024-01-01 to 2024-09-30176USD274
2023-07-01 to 2023-09-3059USD92
2023-01-01 to 2023-09-30176USD273

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2024-07-01 to 2024-09-30536USD92
2024-01-01 to 2024-09-301,617USD274
2023-07-01 to 2023-09-30548USD92
2023-01-01 to 2023-09-301,652USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-1,053,045USD92
2024-01-01 to 2024-09-30-1,074,068USD274
2023-07-01 to 2023-09-30-22,406USD92
2023-01-01 to 2023-09-30-69,842USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2024-01-01 to 2024-09-305,771USD274
2023-01-01 to 2023-09-3016,958USD273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2024-01-01 to 2024-09-30800USD274
2023-01-01 to 2023-09-303,200USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-09-3065,470USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-09-3019,655USD274
2023-01-01 to 2023-09-30-7,100USD273

Inspect the source

Entity
BIO ESSENCE CORP. / CIK 0001723059
Captured
2026-09-21T17:27:22.070Z
SEC response SHA-256
c565ac0ada9acac433d9d3ce0585ef488a941f4edaa321f84fc2ccaeabe2c67c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001723059.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))